Profitable Aphria (TSX:APHA) Stock Earnings Take Centre Stage

Aphria (TSX:APHA)(NYSE:APHA) stock jumped nicely by about 20% this morning after reporting its second profitable earnings this morning.

Cannabis stocks have been going through a beating lately. Luckily for Aphria (TSX:APHA)(NYSE:APHA) shareholders, things may be turning around. The stock jumped nicely by about 20% this morning after reporting its second profitable earnings.

Net revenue came in at $126.1 million last quarter, an increase of 849% over the prior-year quarter.  Moreover, Aphria sold 5,969-kilogram equivalents of inventory, up from 5,574 kilograms from the previous quarter. These are fantastic results, and demand is soaring for the stock.

Canopy Growth (TSX: WEED)(NYSE:CGC) also made two market-moving announcements this morning. Canopy Growth leadership has a habit of hijacking the earnings spotlight from its competitors. In August, Canopy Growth made two game-changing announcements the same morning that the Cronos Group reported its second-quarter earnings.

Canopy also rose modestly in price today, albeit not as much as Aphria. The struggling marijuana stock has lost over half its value in the past six months. Cannabis speculators began driving the stock price up on Canopy Growth at the end of 2017, creating a bubble. The stock has been in correction territory this year.

Canopy Growth sells stake in AusCann

Canopy Growth sold all its shares in the Australian cannabis company, AusCann Group, for $6.3 million at $0.15 per share. Before the sale, Canopy Growth owned a 13.2% interest in AusCann.

Canopy Growth CEO Mark Zekulin released the following statement regarding the sale:

“The decision to divest our position in AusCann, which we obtained three years ago in exchange for the support provided, will allow us to sharpen our focus on our wholly-owned operations in the market while continuing to collaborate with our partners at AusCann.”

The new CEO remains optimistic about the Australian cannabis industry and wants to retain the relationship they built with AusCann while directing that capital to higher value use.

Mark Zekulin replaced the founder and prior CEO Bruce Linton this year when Constellation Brands fired him, disappointing many loyal shareholders.

Canopy Growth acquires Beckley Canopy Therapeutics

Beckley Canopy is a global CBD research firm now wholly owned by Canopy Growth. The acquisition includes the joint commercial venture Spectrum Biomedical UK.

Canopy Growth hopes that the acquisition will increase the competitiveness of the clinical research divisions in Europe and the United Kingdom.

Shareholders should expect Canopy Growth to gain some organizational efficiency from the transition. Multiple departments performing similar functions run the risk of duplicating work, burdening the company with unnecessary costs.

Foolish takeaway

After a brutal year for cannabis stocks, Canadian investors are overdue for a turnaround in the industry. Aphria earnings shed a lot of optimism on this quarter’s earnings season and high expectations for its TSX peers.

You can also expect Canopy Growth to continue fighting for the limelight when its competitors report earnings.

Cannabis is about to take off for the still-undervalued stocks like Aphria. Canadians who still haven’t invested in this newly legal industry should start researching their options.

New industries like cannabis have the highest growth prospects on the Toronto Stock Exchange. Canadian savers should be looking to invest in tomorrow’s cannabis leaders. Because Aphria is still only $5.36 per share at the time of writing, it is one of the best cannabis stocks in which to purchase shares.

Fool contributor Debra Ray has no position in any of the stocks mentioned.

More on Stocks for Beginners

shopper chooses vegetables at grocery store
Dividend Stocks

Loblaw vs. Empire: Which Grocery Stock Would I Choose for Long-Term Growth?

Both grocers benefit from repeat shoppers. I’d give Loblaw the edge for the ways it can earn more from those…

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

2 Top TSX ETFs to Buy and Hold in a TFSA Forever

Looking for top TSX ETFs for your TFSA? Explore how VFV and VDY combine U.S. stock exposure and Canadian dividends…

Read more »

middle-aged couple work together on laptop
Dividend Stocks

Dividend Income Outside a TFSA? The OAS Math I’d Check Before Buying More

A $1,000 dividend can add $1,380 to the income used to calculate your Old Age Security recovery tax.

Read more »

Senior uses a laptop computer
Energy Stocks

Enbridge vs. TC Energy: Which Pipeline Stock Fits a Retirement Portfolio?

Enbridge gives me the bigger cheque today. TC Energy makes a case for investors who want more exposure to growing…

Read more »

electrical cord plugs into wall socket for more energy
Energy Stocks

What $10,000 in Fortis Could Pay Now After Years of Dividend Growth

A $10,000 Fortis purchase could start with about $311 in annual dividends. Future raises are where the numbers get more…

Read more »

some investments are riskier than others
Dividend Stocks

5 Top Canadian Stocks to Buy and Hold With $1,000

Get tips on buying and holding stocks with strategic insights to maximize your investment returns and manage risks.

Read more »

Hourglass projecting a dollar sign as shadow
Stocks for Beginners

It’s Time to Buy: 1 Canadian Stock That Hasn’t Been This Cheap in Years

This Canadian stock has plunged nearly 49% in six months, but improving orders and major cost-saving initiatives could make this…

Read more »

data analyze research
Stocks for Beginners

TD’s Dividend Is Only Half the Investment Case: Here’s the Recovery Math

TD’s dividend pays you while you wait. The bigger payoff depends on how much more the bank can earn from…

Read more »